<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2020-10-07" version="224">
<accession>Q06830</accession>
<accession>B5BU26</accession>
<accession>D3DPZ8</accession>
<accession>P35703</accession>
<accession>Q2V576</accession>
<accession>Q5T154</accession>
<accession>Q5T155</accession>
<name>PRDX1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Peroxiredoxin-1</fullName>
<ecNumber evidence="13 23">1.11.1.24</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Natural killer cell-enhancing factor A</fullName>
<shortName>NKEF-A</shortName>
</alternativeName>
<alternativeName>
<fullName>Proliferation-associated gene protein</fullName>
<shortName>PAG</shortName>
</alternativeName>
<alternativeName>
<fullName>Thioredoxin peroxidase 2</fullName>
</alternativeName>
<alternativeName>
<fullName>Thioredoxin-dependent peroxide reductase 2</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="26">Thioredoxin-dependent peroxiredoxin 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">PRDX1</name>
<name type="synonym">PAGA</name>
<name type="synonym">PAGB</name>
<name type="synonym">TDPX2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="J. Biol. Chem." volume="268" first="11050" last="11056">
<title>A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins.</title>
<authorList>
<person name="Prosperi M.T."/>
<person name="Ferbus D."/>
<person name="Karczinski I."/>
<person name="Goubin G."/>
</authorList>
<dbReference type="PubMed" id="8496166"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Immunogenetics" volume="40" first="129" last="134">
<title>Cloning and sequence analysis of candidate human natural killer-enhancing factor genes.</title>
<authorList>
<person name="Shau H."/>
<person name="Butterfield L.H."/>
<person name="Chiu R."/>
<person name="Kim A."/>
</authorList>
<dbReference type="PubMed" id="8026862"/>
<dbReference type="DOI" id="10.1007/bf00188176"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full-length CDSs in BD Creator(TM) system donor vector.</title>
<authorList>
<person name="Kalnine N."/>
<person name="Chen X."/>
<person name="Rolfs A."/>
<person name="Halleck A."/>
<person name="Hines L."/>
<person name="Eisenstein S."/>
<person name="Koundinya M."/>
<person name="Raphael J."/>
<person name="Moreira D."/>
<person name="Kelley T."/>
<person name="LaBaer J."/>
<person name="Lin Y."/>
<person name="Phelan M."/>
<person name="Farmer A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2004-05" db="EMBL/GenBank/DDBJ databases">
<title>Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201).</title>
<authorList>
<person name="Ebert L."/>
<person name="Schick M."/>
<person name="Neubert P."/>
<person name="Schatten R."/>
<person name="Henze S."/>
<person name="Korn B."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT GLY-62</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="2008-12" db="UniProtKB">
<authorList>
<person name="Lubec G."/>
<person name="Afjehi-Sadat L."/>
<person name="Chen W.-Q."/>
<person name="Sun Y."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 17-35; 93-136; 141-151 AND 159-190</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Brain</tissue>
<tissue>Cajal-Retzius cell</tissue>
<tissue>Fetal brain cortex</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="6297" last="6302">
<title>Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha.</title>
<authorList>
<person name="Kang S.W."/>
<person name="Chae H.Z."/>
<person name="Seo M.S."/>
<person name="Kim K."/>
<person name="Baines I.C."/>
<person name="Rhee S.G."/>
</authorList>
<dbReference type="PubMed" id="9497357"/>
<dbReference type="DOI" id="10.1074/jbc.273.11.6297"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Biochem. J." volume="366" first="777" last="785">
<title>A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress.</title>
<authorList>
<person name="Wagner E."/>
<person name="Luche S."/>
<person name="Penna L."/>
<person name="Chevallet M."/>
<person name="van Dorsselaer A."/>
<person name="Leize-Wagner E."/>
<person name="Rabilloud T."/>
</authorList>
<dbReference type="PubMed" id="12059788"/>
<dbReference type="DOI" id="10.1042/bj20020525"/>
</citation>
<scope>OVEROXIDATION AT CYS-52</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="25370" last="25376">
<title>Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation.</title>
<authorList>
<person name="Chang T.-S."/>
<person name="Jeong W."/>
<person name="Choi S.Y."/>
<person name="Yu S."/>
<person name="Kang S.W."/>
<person name="Rhee S.G."/>
</authorList>
<dbReference type="PubMed" id="11986303"/>
<dbReference type="DOI" id="10.1074/jbc.m110432200"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT THR-90</scope>
<scope>MUTAGENESIS OF THR-90</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="38029" last="38036">
<title>Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid.</title>
<authorList>
<person name="Yang K.S."/>
<person name="Kang S.W."/>
<person name="Woo H.A."/>
<person name="Hwang S.C."/>
<person name="Chae H.Z."/>
<person name="Kim K."/>
<person name="Rhee S.G."/>
</authorList>
<dbReference type="PubMed" id="12161445"/>
<dbReference type="DOI" id="10.1074/jbc.m206626200"/>
</citation>
<scope>OVEROXIDATION AT CYS-52</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="37146" last="37153">
<title>Regeneration of peroxiredoxins during recovery after oxidative stress: only some overoxidized peroxiredoxins can be reduced during recovery after oxidative stress.</title>
<authorList>
<person name="Chevallet M."/>
<person name="Wagner E."/>
<person name="Luche S."/>
<person name="van Dorsselaer A."/>
<person name="Leize-Wagner E."/>
<person name="Rabilloud T."/>
</authorList>
<dbReference type="PubMed" id="12853451"/>
<dbReference type="DOI" id="10.1074/jbc.m305161200"/>
</citation>
<scope>RETROREDUCTION OF CYS-52</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="17">
<citation type="journal article" date="2003" name="Science" volume="300" first="653" last="656">
<title>Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation.</title>
<authorList>
<person name="Woo H.A."/>
<person name="Chae H.Z."/>
<person name="Hwang S.C."/>
<person name="Yang K.S."/>
<person name="Kang S.W."/>
<person name="Kim K."/>
<person name="Rhee S.G."/>
</authorList>
<dbReference type="PubMed" id="12714748"/>
<dbReference type="DOI" id="10.1126/science.1080273"/>
</citation>
<scope>RETROREDUCTION OF CYS-52</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2004" name="Science" volume="304" first="596" last="600">
<title>Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD.</title>
<authorList>
<person name="Budanov A.V."/>
<person name="Sablina A.A."/>
<person name="Feinstein E."/>
<person name="Koonin E.V."/>
<person name="Chumakov P.M."/>
</authorList>
<dbReference type="PubMed" id="15105503"/>
<dbReference type="DOI" id="10.1126/science.1095569"/>
</citation>
<scope>INTERACTION WITH SESN1 AND SESN2</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="J. Proteome Res." volume="5" first="3135" last="3144">
<title>Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.</title>
<authorList>
<person name="Chi A."/>
<person name="Valencia J.C."/>
<person name="Hu Z.-Z."/>
<person name="Watabe H."/>
<person name="Yamaguchi H."/>
<person name="Mangini N.J."/>
<person name="Huang H."/>
<person name="Canfield V.A."/>
<person name="Cheng K.C."/>
<person name="Yang F."/>
<person name="Abe R."/>
<person name="Yamagishi S."/>
<person name="Shabanowitz J."/>
<person name="Hearing V.J."/>
<person name="Wu C."/>
<person name="Appella E."/>
<person name="Hunt D.F."/>
</authorList>
<dbReference type="PubMed" id="17081065"/>
<dbReference type="DOI" id="10.1021/pr060363j"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Melanoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-7; LYS-16; LYS-27 AND LYS-35</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="17213" last="17218">
<title>Tumor suppressor down-regulated in renal cell carcinoma 1 (DRR1) is a stress-induced actin bundling factor that modulates synaptic efficacy and cognition.</title>
<authorList>
<person name="Schmidt M.V."/>
<person name="Schuelke J.P."/>
<person name="Liebl C."/>
<person name="Stiess M."/>
<person name="Avrabos C."/>
<person name="Bock J."/>
<person name="Wochnik G.M."/>
<person name="Davies H.A."/>
<person name="Zimmermann N."/>
<person name="Scharf S.H."/>
<person name="Truembach D."/>
<person name="Wurst W."/>
<person name="Zieglgaensberger W."/>
<person name="Turck C."/>
<person name="Holsboer F."/>
<person name="Stewart M.G."/>
<person name="Bradke F."/>
<person name="Eder M."/>
<person name="Mueller M.B."/>
<person name="Rein T."/>
</authorList>
<dbReference type="PubMed" id="21969592"/>
<dbReference type="DOI" id="10.1073/pnas.1103318108"/>
</citation>
<scope>INTERACTION WITH FAM107A</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2012" name="J. Proteome Res." volume="11" first="4733" last="4743">
<title>Resveratrol-induced changes of the human adipocyte secretion profile.</title>
<authorList>
<person name="Rosenow A."/>
<person name="Noben J.P."/>
<person name="Jocken J."/>
<person name="Kallendrusch S."/>
<person name="Fischer-Posovszky P."/>
<person name="Mariman E.C."/>
<person name="Renes J."/>
</authorList>
<dbReference type="PubMed" id="22905912"/>
<dbReference type="DOI" id="10.1021/pr300539b"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-185</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2015" name="Proteomics" volume="15" first="2519" last="2524">
<title>N-terminome analysis of the human mitochondrial proteome.</title>
<authorList>
<person name="Vaca Jacome A.S."/>
<person name="Rabilloud T."/>
<person name="Schaeffer-Reiss C."/>
<person name="Rompais M."/>
<person name="Ayoub D."/>
<person name="Lane L."/>
<person name="Bairoch A."/>
<person name="Van Dorsselaer A."/>
<person name="Carapito C."/>
</authorList>
<dbReference type="PubMed" id="25944712"/>
<dbReference type="DOI" id="10.1002/pmic.201400617"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-7 AND LYS-120</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Nature" volume="451" first="98" last="101">
<title>Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace.</title>
<authorList>
<person name="Joensson T.J."/>
<person name="Johnson L.C."/>
<person name="Lowther W.T."/>
</authorList>
<dbReference type="PubMed" id="18172504"/>
<dbReference type="DOI" id="10.1038/nature06415"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH SRXN1</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2009" name="J. Biol. Chem." volume="284" first="33305" last="33310">
<title>Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation.</title>
<authorList>
<person name="Joensson T.J."/>
<person name="Johnson L.C."/>
<person name="Lowther W.T."/>
</authorList>
<dbReference type="PubMed" id="19812042"/>
<dbReference type="DOI" id="10.1074/jbc.m109.036400"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS)</scope>
</reference>
<reference key="31" evidence="3">
<citation type="journal article" date="2015" name="Bull. Korean Chem. Soc." volume="36" first="1543" last="1545">
<title>Crystal structure of dimeric human peroxiredoxin-1 C83S mutant.</title>
<authorList>
<person name="Cho K.J."/>
<person name="Park Y."/>
<person name="Khan T.G."/>
<person name="Lee J.-H."/>
<person name="Kim S."/>
<person name="Seok J.H."/>
<person name="Chung Y.B."/>
<person name="Cho A.E."/>
<person name="Choi Y."/>
<person name="Chang T.-S."/>
<person name="Kim K.H."/>
</authorList>
<dbReference type="DOI" id="10.1002/bkcs.10284"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS)</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<comment type="function">
<text evidence="10 23">Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (PubMed:9497357). Reduces an intramolecular disulfide bond in GDPD5 that gates the ability to GDPD5 to drive postmitotic motor neuron differentiation (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="13 23">
<text>[thioredoxin]-dithiol + a hydroperoxide = [thioredoxin]-disulfide + an alcohol + H2O</text>
<dbReference type="Rhea" id="RHEA:62620"/>
<dbReference type="Rhea" id="RHEA-COMP:10698"/>
<dbReference type="Rhea" id="RHEA-COMP:10700"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:29950"/>
<dbReference type="ChEBI" id="CHEBI:30879"/>
<dbReference type="ChEBI" id="CHEBI:35924"/>
<dbReference type="ChEBI" id="CHEBI:50058"/>
<dbReference type="EC" id="1.11.1.24"/>
</reaction>
</comment>
<comment type="subunit">
<text evidence="10 18 20 22">Homodimer; disulfide-linked, upon oxidation. 5 homodimers assemble to form a ring-like decamer (PubMed:18172504). Interacts with GDPD5; forms a mixed-disulfide with GDPD5 (By similarity). Interacts with SESN1 and SESN2 (PubMed:15105503). Interacts with FAM107A (PubMed:21969592).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-977302">
<id>P04156</id>
<label>PRNP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-696162">
<id>P60484</id>
<label>PTEN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-15678820">
<id>Q9BYN0</id>
<label>SRXN1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-367376">
<id>Q13043</id>
<label>STK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>11</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-710997">
<id>P54274</id>
<label>TERF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-353193">
<id>Q06830</id>
</interactant>
<interactant intactId="EBI-1783169">
<id>P13693</id>
<label>TPT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="19 23">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19">Melanosome</location>
</subcellularLocation>
<text>Identified by mass spectrometry in melanosome fractions from stage I to stage IV.</text>
</comment>
<comment type="induction">
<text>Constitutively expressed in most human cells; is induced to higher levels upon serum stimulation in untransformed and transformed cells.</text>
</comment>
<comment type="PTM">
<text evidence="13">Phosphorylated on Thr-90 during the M-phase, which leads to a more than 80% decrease in enzymatic activity.</text>
</comment>
<comment type="PTM">
<text evidence="14 15 16 17 20 21">The enzyme can be inactivated by further oxidation of the cysteine sulfenic acid (C(P)-SOH) to sulphinic acid (C(P)-SO2H) instead of its condensation to a disulfide bond. It can be reactivated by forming a transient disulfide bond with sulfiredoxin SRXN1, which reduces the cysteine sulfinic acid in an ATP- and Mg-dependent manner.</text>
</comment>
<comment type="miscellaneous">
<text evidence="29">The active site is a conserved redox-active cysteine residue, the peroxidatic cysteine (C(P)), which makes the nucleophilic attack on the peroxide substrate. The peroxide oxidizes the C(P)-SH to cysteine sulfenic acid (C(P)-SOH), which then reacts with another cysteine residue, the resolving cysteine (C(R)), to form a disulfide bridge. The disulfide is subsequently reduced by an appropriate electron donor to complete the catalytic cycle. In this typical 2-Cys peroxiredoxin, C(R) is provided by the other dimeric subunit to form an intersubunit disulfide. The disulfide is subsequently reduced by thioredoxin.</text>
</comment>
<comment type="similarity">
<text evidence="26">Belongs to the peroxiredoxin family. AhpC/Prx1 subfamily.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/PAGID266.html"/>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/prdx1/"/>
</comment>
<dbReference type="EC" id="1.11.1.24" evidence="13 23"/>
<dbReference type="EMBL" id="X67951">
<property type="protein sequence ID" value="CAA48137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="L19184">
<property type="protein sequence ID" value="AAA50464.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BT019740">
<property type="protein sequence ID" value="AAV38545.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR407652">
<property type="protein sequence ID" value="CAG28580.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ297142">
<property type="protein sequence ID" value="ABB84465.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451262">
<property type="protein sequence ID" value="BAG70076.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451388">
<property type="protein sequence ID" value="BAG70202.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL451136">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06975.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06976.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06978.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06979.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06980.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06981.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471059">
<property type="protein sequence ID" value="EAX06982.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC007063">
<property type="protein sequence ID" value="AAH07063.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC021683">
<property type="protein sequence ID" value="AAH21683.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS522.1"/>
<dbReference type="PIR" id="A46711">
<property type="entry name" value="A46711"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001189360.1">
<property type="nucleotide sequence ID" value="NM_001202431.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002565.1">
<property type="nucleotide sequence ID" value="NM_002574.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_859047.1">
<property type="nucleotide sequence ID" value="NM_181696.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_859048.1">
<property type="nucleotide sequence ID" value="NM_181697.2"/>
</dbReference>
<dbReference type="PDB" id="2RII">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=1-199"/>
</dbReference>
<dbReference type="PDB" id="3HY2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=1-199"/>
</dbReference>
<dbReference type="PDB" id="4XCS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B/C/D/E/F=1-199"/>
</dbReference>
<dbReference type="PDBsum" id="2RII"/>
<dbReference type="PDBsum" id="3HY2"/>
<dbReference type="PDBsum" id="4XCS"/>
<dbReference type="SMR" id="Q06830"/>
<dbReference type="BioGRID" id="111089">
<property type="interactions" value="209"/>
</dbReference>
<dbReference type="CORUM" id="Q06830"/>
<dbReference type="DIP" id="DIP-33152N"/>
<dbReference type="IntAct" id="Q06830">
<property type="interactions" value="95"/>
</dbReference>
<dbReference type="MINT" id="Q06830"/>
<dbReference type="STRING" id="9606.ENSP00000262746"/>
<dbReference type="ChEMBL" id="CHEMBL5315"/>
<dbReference type="DrugBank" id="DB11638">
<property type="generic name" value="Artenimol"/>
</dbReference>
<dbReference type="DrugBank" id="DB09130">
<property type="generic name" value="Copper"/>
</dbReference>
<dbReference type="DrugBank" id="DB09221">
<property type="generic name" value="Polaprezinc"/>
</dbReference>
<dbReference type="DrugBank" id="DB01593">
<property type="generic name" value="Zinc"/>
</dbReference>
<dbReference type="DrugBank" id="DB14487">
<property type="generic name" value="Zinc acetate"/>
</dbReference>
<dbReference type="DrugBank" id="DB14533">
<property type="generic name" value="Zinc chloride"/>
</dbReference>
<dbReference type="DrugBank" id="DB14548">
<property type="generic name" value="Zinc sulfate, unspecified form"/>
</dbReference>
<dbReference type="PeroxiBase" id="4501">
<property type="entry name" value="Hs2CysPrx01"/>
</dbReference>
<dbReference type="iPTMnet" id="Q06830"/>
<dbReference type="MetOSite" id="Q06830"/>
<dbReference type="PhosphoSitePlus" id="Q06830"/>
<dbReference type="SwissPalm" id="Q06830"/>
<dbReference type="BioMuta" id="PRDX1"/>
<dbReference type="DMDM" id="548453"/>
<dbReference type="DOSAC-COBS-2DPAGE" id="Q06830"/>
<dbReference type="OGP" id="Q06830"/>
<dbReference type="SWISS-2DPAGE" id="Q06830"/>
<dbReference type="UCD-2DPAGE" id="Q06830"/>
<dbReference type="EPD" id="Q06830"/>
<dbReference type="jPOST" id="Q06830"/>
<dbReference type="MassIVE" id="Q06830"/>
<dbReference type="MaxQB" id="Q06830"/>
<dbReference type="PaxDb" id="Q06830"/>
<dbReference type="PeptideAtlas" id="Q06830"/>
<dbReference type="PRIDE" id="Q06830"/>
<dbReference type="ProteomicsDB" id="12697"/>
<dbReference type="ProteomicsDB" id="58486"/>
<dbReference type="TopDownProteomics" id="Q06830"/>
<dbReference type="Antibodypedia" id="1574">
<property type="antibodies" value="666 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5052"/>
<dbReference type="Ensembl" id="ENST00000262746">
<property type="protein sequence ID" value="ENSP00000262746"/>
<property type="gene ID" value="ENSG00000117450"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000319248">
<property type="protein sequence ID" value="ENSP00000361152"/>
<property type="gene ID" value="ENSG00000117450"/>
</dbReference>
<dbReference type="GeneID" id="5052"/>
<dbReference type="KEGG" id="hsa:5052"/>
<dbReference type="UCSC" id="uc001coa.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5052"/>
<dbReference type="DisGeNET" id="5052"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000117450.13"/>
<dbReference type="GeneCards" id="PRDX1"/>
<dbReference type="HGNC" id="HGNC:9352">
<property type="gene designation" value="PRDX1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000117450">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="PRDX1"/>
<dbReference type="MIM" id="176763">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q06830"/>
<dbReference type="OpenTargets" id="ENSG00000117450"/>
<dbReference type="PharmGKB" id="PA33722"/>
<dbReference type="eggNOG" id="KOG0852">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000154277"/>
<dbReference type="InParanoid" id="Q06830"/>
<dbReference type="KO" id="K13279"/>
<dbReference type="OMA" id="FWYPKDF"/>
<dbReference type="OrthoDB" id="1326484at2759"/>
<dbReference type="PhylomeDB" id="Q06830"/>
<dbReference type="TreeFam" id="TF105181"/>
<dbReference type="BioCyc" id="MetaCyc:HS04134-MONOMER"/>
<dbReference type="BRENDA" id="1.11.1.15">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="PathwayCommons" id="Q06830"/>
<dbReference type="Reactome" id="R-HSA-3299685">
<property type="pathway name" value="Detoxification of Reactive Oxygen Species"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5628897">
<property type="pathway name" value="TP53 Regulates Metabolic Genes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8862803">
<property type="pathway name" value="Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models"/>
</dbReference>
<dbReference type="SIGNOR" id="Q06830"/>
<dbReference type="BioGRID-ORCS" id="5052">
<property type="hits" value="50 hits in 887 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PRDX1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q06830"/>
<dbReference type="GeneWiki" id="Peroxiredoxin_1"/>
<dbReference type="GenomeRNAi" id="5052"/>
<dbReference type="Pharos" id="Q06830">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q06830"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q06830">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000117450">
<property type="expression patterns" value="Expressed in thyroid gland and 241 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q06830">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q06830">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042470">
<property type="term" value="C:melanosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0045296">
<property type="term" value="F:cadherin binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0004601">
<property type="term" value="F:peroxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008379">
<property type="term" value="F:thioredoxin peroxidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell population proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0045454">
<property type="term" value="P:cell redox homeostasis"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034101">
<property type="term" value="P:erythrocyte homeostasis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0042744">
<property type="term" value="P:hydrogen peroxide catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045321">
<property type="term" value="P:leukocyte activation"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030101">
<property type="term" value="P:natural killer cell activation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042267">
<property type="term" value="P:natural killer cell mediated cytotoxicity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1901222">
<property type="term" value="P:regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032872">
<property type="term" value="P:regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0019430">
<property type="term" value="P:removal of superoxide radicals"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006979">
<property type="term" value="P:response to oxidative stress"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0001895">
<property type="term" value="P:retina homeostasis"/>
<property type="evidence" value="ECO:0007007"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001501">
<property type="term" value="P:skeletal system development"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="Gene3D" id="3.40.30.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR000866">
<property type="entry name" value="AhpC/TSA"/>
</dbReference>
<dbReference type="InterPro" id="IPR024706">
<property type="entry name" value="Peroxiredoxin_AhpC-typ"/>
</dbReference>
<dbReference type="InterPro" id="IPR019479">
<property type="entry name" value="Peroxiredoxin_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR036249">
<property type="entry name" value="Thioredoxin-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR013766">
<property type="entry name" value="Thioredoxin_domain"/>
</dbReference>
<dbReference type="Pfam" id="PF10417">
<property type="entry name" value="1-cysPrx_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00578">
<property type="entry name" value="AhpC-TSA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF000239">
<property type="entry name" value="AHPC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52833">
<property type="entry name" value="SSF52833"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51352">
<property type="entry name" value="THIOREDOXIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0049">Antioxidant</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0575">Peroxidase</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0676">Redox-active center</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Peroxiredoxin-1" id="PRO_0000135076">
<location>
<begin position="2"/>
<end position="199"/>
</location>
</feature>
<feature type="domain" description="Thioredoxin" evidence="12">
<location>
<begin position="6"/>
<end position="165"/>
</location>
</feature>
<feature type="active site" description="Cysteine sulfenic acid (-SOH) intermediate" evidence="27 28">
<location>
<position position="52"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="16"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="4">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6">
<location>
<position position="32"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="4">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="N6-succinyllysine; alternate" evidence="11">
<location>
<position position="35"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by CDK1" evidence="13">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="11">
<location>
<position position="136"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-173); in linked form" evidence="3 24">
<location>
<position position="52"/>
</location>
</feature>
<feature type="disulfide bond" description="Interchain (with C-52); in linked form" evidence="3 24">
<location>
<position position="173"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="9">
<location>
<position position="7"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="9">
<location>
<position position="120"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1)" evidence="7">
<location>
<position position="185"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34034070." id="VAR_025050" evidence="25">
<original>R</original>
<variation>G</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes phosphorylation by CDK1; 30% reduction in enzymatic activity." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="87% reduction in enzymatic activity." evidence="13">
<original>T</original>
<variation>D</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="26">
<original>L</original>
<variation>P</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="26">
<original>VG</original>
<variation>CC</variation>
<location>
<begin position="149"/>
<end position="150"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="26">
<original>Q</original>
<variation>P</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2." ref="2" evidence="26">
<original>S</original>
<variation>T</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="2"/>
<end position="5"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="16"/>
<end position="20"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="26"/>
<end position="30"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="31"/>
<end position="34"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="37"/>
<end position="43"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="54"/>
<end position="61"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="63"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="71"/>
<end position="79"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="81"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="92"/>
<end position="94"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="104"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="111"/>
<end position="115"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="121"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="124"/>
<end position="126"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="128"/>
<end position="133"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="137"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="153"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="169"/>
<end position="171"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="181"/>
<end position="183"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2RII"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3HY2"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4XCS"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25944712"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P0CB50"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P35700"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00691"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11986303"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12059788"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12161445"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12714748"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12853451"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15105503"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17081065"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18172504"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19812042"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21969592"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9497357"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source ref="31"/>
</evidence>
<evidence key="25" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="26" type="ECO:0000305"/>
<evidence key="27" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12059788"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="12161445"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000305">
<source ref="31"/>
</evidence>
<sequence length="199" mass="22110" checksum="8F68E56D75BF5304" modified="1994-06-01" version="1">MSSGNAKIGHPAPNFKATAVMPDGQFKDISLSDYKGKYVVFFFYPLDFTFVCPTEIIAFSDRAEEFKKLNCQVIGASVDSHFCHLAWVNTPKKQGGLGPMNIPLVSDPKRTIAQDYGVLKADEGISFRGLFIIDDKGILRQITVNDLPVGRSVDETLRLVQAFQFTDKHGEVCPAGWKPGSDTIKPDVQKSKEYFSKQK</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

